Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its...
March 2025
A chance discovery led a team of scientists from Rice University, University of Cambridge and...
Late last week, the FDA approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce...
The sudden but not altogether surprising departure of Peter Marks, MD, from the FDA has...
In recent years, the therapeutic landscape for type 2 diabetes has witnessed groundbreaking advancements, particularly...
A new and pivotal study led by researchers at Intermountain Health in Salt Lake City...
In recent research published in JAMA Cardiology, the therapeutic efficacy of finerenone has been evaluated,...
A recent study conducted by researchers at Intermountain Health in Salt Lake City has provided...
The advent of novel approaches to cardiovascular research is critical in advancing our understanding of...
The Journal of the American College of Cardiology (JACC), an esteemed publication in the field...